157 Participants Needed

Low-Cost Imaging for Cervical Cancer

Age: 18+
Sex: Female
Trial Phase: Phase < 1
Sponsor: The University of Texas Medical Branch, Galveston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" (HRME) for the diagnosis of cervical pre-cancerous lesions and cervical cancer. The investigators want to compare patients' clinical findings using the current equipment used in clinic with the clinical findings using new equipment we are testing on this research project. If the new equipment is proven to give comparable findings with current equipment being used, doctors might be able to offer a diagnosis and treat cervical lesions in one visit. It might not be necessary to wait for cervical biopsies to come back before women would receive the indicated treatment. Study subjects are being asked to participate because they have been diagnosed with an abnormal Papanicolaou (Pap) PAP smear, positive human papillomavirus (HPV) test or history of cervical dysplasia and need to have a colposcopic examination to determine the reason for abnormal results and receive treatment.

Research Team

Kathleen M. Schmeler | MD Anderson ...

Kathleen M. Schmeler

Principal Investigator

M.D. Anderson Cancer Center

AM

Ana M Rodriguez, MD

Principal Investigator

University of Texas Medical Branch (UTMB)

Eligibility Criteria

This trial is for women over 21 with an intact cervix who have had abnormal Pap tests, positive HPV tests, or a history of cervical dysplasia. It includes those who've had treatments like LEEP, cone, or cryotherapy. Pregnant or nursing women and those allergic to proflavine or iodine can't join.

Inclusion Criteria

Ability to understand and the willingness to provide informed consent and sign a written Informed Consent Document (ICD)
I am a woman with an intact cervix, even if I've had certain cervical procedures.
I have had an abnormal Pap test, a positive HPV test, or a history of cervical dysplasia.
See 3 more

Exclusion Criteria

I am not pregnant or nursing.
I am allergic to proflavine, acriflavine, or iodine.
I am a woman under 21 years old.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Examination and Imaging

Participants undergo standard colposcopy followed by high-resolution microendoscopy imaging with Proflavine 0.01% application

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the imaging procedure

4 weeks

Treatment Details

Interventions

  • High-Resolution Microendoscopy (HRME)
Trial Overview The study is testing the High-Resolution Microendoscope (HRME) against current clinical equipment for diagnosing cervical pre-cancer and cancer. The goal is to see if HRME can provide immediate diagnosis without waiting for biopsy results.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: High-Resolution Microendoscopy (HRME)Experimental Treatment2 Interventions
After standard colposcopy examination performed, participants undergo a high-resolution microendoscopy imaging procedure. Proflavine 0.01% is applied to the cervix, then high-resolution microendoscopy imaging procedure performed. Standard colposcopy procedure will then continue.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Medical Branch, Galveston

Lead Sponsor

Trials
263
Recruited
55,400+

William Marsh Rice University

Collaborator

Trials
50
Recruited
28,400+

M.D. Anderson Cancer Center

Collaborator

Trials
3,107
Recruited
1,813,000+

The University of Texas Health Science Center, Houston

Collaborator

Trials
974
Recruited
361,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security